Top Biomed Stock
Report Date: 03-17-2024
Symbol: ELDN - Eledon Pharmaceuticals, Inc.
Sector:
Industry:
Top Biomed Stock Signal: ELDN
Eledon Pharmaceuticals, Inc. (ELDN)
19900 MacArthur Boulevard
Irvine, CA 92612
Phone: 949 238 8090
Website: https://eledon.com
CEO:
Eledon Pharmaceuticals, Inc., clinical stage biopharmaceutical company, focuses on developing medicines for the patients living with autoimmune disease and amyotrophic lateral sclerosis (ALS), and requiring an organ or cell-based transplant. Its lead product candidate includes AT-1501, a humanized monoclonal antibody to target CD40 Ligand that is a molecule expressed on the surface of human immune system T cells, which is in Phase 2a clinical trials for the treatment of ALS, and Phase 2 clinical trials in islet cell transplantation for the treatment of type 1 diabetes. The company was formerly known as Novus Therapeutics, Inc. and changed its name to Eledon Pharmaceuticals, Inc. in January 2021. Eledon Pharmaceuticals, Inc. is headquartered in Irvine, California.